Repositionable electrode and systems and methods for identifying electrode position for cardiotherapy

• US 8,948,885 B2
• Filed: 11/03/2008
• Issued: 02/03/2015
• Est. Priority Date: 11/08/2007
• Status: Active Grant

• Current Assignee: Koninklijke Philips Electronics N.V. (Koninklijke Philips N.V.)
• Original Assignee: Koninklijke Philips N.V.
• Inventors: Russell, James K.
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): Patel, Natasha
• Application Number:
  US12/739,446
• Publication Number:
  US 20100234909A1
• Time in Patent Office: 2,283 Days
• Field of Search: 600/509, 600/522, 600/523, 600/546, 600/547, 600/391, 600/392, 607/142
• US Class Current: 607/142
• CPC Class Codes: A61B 5/363 Detecting tachycardia or bradycardia
• CPC Class Codes: A61B 5/7221 Determining signal validity, reliability or quality A61B5/7207 and A61B5/7217 take precedence
• CPC Class Codes: A61N 1/046 Specially adapted for shock therapy, e.g. defibrillation
• CPC Class Codes: A61N 1/0476 Array electrodes (including any electrode arrangement with more than one electrode for at least one of the polarities)
• CPC Class Codes: A61N 1/0492 Patch electrodes A61N1/0412, A61N1/0428 take precedence
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting

Abstract

A system and method for positioning an electrode for cardiotherapy of atrial arrhythmia are described. Signals from patient electrical activity for a plurality of electrode locations on a patient are analyzed. An electrode can be repositioned to different locations on the patient to obtain signals from patient electrical activity therefrom. A human perceptible output indicative of the quality of the signals for the plurality of locations is generated and a final electrode location on the patient for placement of the electrode for cardiotherapy is identified based on the human perceptible output.

Claims

1. A system for treating heart arrhythmia comprising:

at least one electrode configured to be repositioned to a plurality of locations on a patient'"'"'s skin and conduct electrical activity corresponding to the patient, wherein the electrode further comprises

a substrate,

a conductor disposed on a lower surface of the substrate,

an electrode having an upper surface contacting the conductor, the electrode adapted to conduct electrical signals to and from a patient'"'"'s skin,

an adhesive lower surface of the electrode, and

first and second release layers having a non-adhesive upper surface extending across portions of the adhesive surface, the release layers comprising a non-conductive material; and

an electrocardiotherapy device electrically coupled to the electrode, the device operable to receive signals corresponding to the electrical activity from the electrode, analyze the received signals, and generate human perceptible output indicative of the quality of the received signals from the plurality of locations,

wherein the electrocardiotherapy device comprises a controller operable to measure a patient ECG from the received signals and further operable to analyze the patient ECG and calculate a measure for atrial signal component strength to generate the human perceptible output indicative of the quality of the received signals,

wherein the electrocardiotherapy device comprises a defibrillator.

2. The system of claim 1, wherein the controller is operable to

calculate a measure for the atrial signal component strength based on the amplitude of the atrial signal component of an ECG signal.

3. The system of claim 2, wherein the controller is operable to calculate a measure for the atrial signal component strength based on the amplitude of the atrial signal component relative to a threshold amplitude.

4. A method for positioning an electrode for cardiotherapy comprising:

analyzing atrial-related signals from patient electrical activity for a plurality of electrode locations on a patient;

generating human perceptible output indicative of the quality of the atrial-related signals for the plurality of locations;

removing a first release layer of the electrode to expose a conductive portion and repositioning the electrode to different locations on the patient to obtain atrial-related signals from patient electrical activity therefrom;

identifying a final electrode location on the patient for placement of the electrode for cardiotherapy based on the human perceptible output; and

removing a second release layer of the electrode to expose an adhesive portion and adhering the electrode to the final electrode location on the patient.

5. The method of claim 4, wherein analyzing signals from patient electrical activity comprises:

measuring patient ECG;

analyzing the patient ECG; and

calculating a measure for atrial signal component strength of the patient ECG.

6. The method of claim 5, wherein calculating the measure for the atrial signal component strength is based on the amplitude of the atrial signal component.

7. The method of claim 6, wherein calculating the measure for the atrial signal component strength is based on the amplitude of the atrial signal component relative to a threshold amplitude.

8. A system for treating heart arrhythmia comprising:

at least one electrode configured to be repositioned to a plurality of locations on a patient'"'"'s skin and conduct electrical activity corresponding to the patient, wherein the electrode further comprises

a substrate,

a conductor disposed on a lower surface of the substrate,

an electrode having an upper surface contacting the conductor, the electrode adapted to conduct electrical signals to and from a patient'"'"'s skin,

an adhesive lower surface of the electrode, and

a release layer having a non-adhesive upper surface extending across the adhesive surface, the release layer comprising a conductive material extending from the upper surface to a lower surface thereof and contacting the electrode; and

an electrocardiotherapy device electrically coupled to the electrode, the device operable to receive signals corresponding to the electrical activity from the electrode, analyze the received signals, and generate human perceptible output indicative of the quality of the received signals from the plurality of locations,

wherein the electrocardiotherapy device comprises a controller operable to measure a patient ECG from the received signals and further operable to analyze the patient ECG and calculate a measure for atrial signal component strength to generate the human perceptible output indicative of the quality of the received signals,

wherein the electrocardiotherapy device comprises a defibrillator.